The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 590.00
Bid: 562.00
Ask: 570.00
Change: 10.00 (1.72%)
Spread: 8.00 (1.423%)
Open: 588.00
High: 590.00
Low: 588.00
Prev. Close: 580.00
GHH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ITL signs manufacturing agreement with OrganOx

13 Mar 2019 07:00

RNS Number : 6541S
Gooch & Housego PLC
13 March 2019
 

 

 13 March 2019

 

RNS REACH

 

 

 

Gooch & Housego PLC

("Gooch & Housego" or the "Company")

 

ITL signs manufacturing agreement with OrganOx

Gooch & Housego PLC (AIM: GHH), the specialist manufacturer of optical components and systems, announces that its life science business ITL has been awarded a five-year contract from OrganOx Limited for the manufacture of metra, an innovative medical device that allows livers for transplant to be stored and transported at body temperature.

The metra system operates by supplying a donated liver with oxygenated blood, anti-clotting drugs and assorted nutrients whilst keeping the organ at a stable temperature (37°C). It has the potential to significantly reduce the number of livers that are discarded due to damage incurred by cold storage or a lack of oxygen.

OrganOx, which was founded in 2008 as a spin-out company from Oxford university, has already gained marketing approval for metra in Europe and is in late stage clinical trials in the US.

Tom Cole, managing director of ITL, said: "We are delighted to be working in partnership with OrganOx on this ground-breaking project. This agreement is yet another important milestone positioning metra as one of the most promising transplantation candidates in late-stage development. This collaboration marks the beginning of what I'm sure will be a very exciting journey for both ITL and OrganOx."

Craig Marshall, CEO of OrganOx, said: "This agreement is strategically important to OrganOx as we prepare to penetrate the US market. I have a manufacturing background and I know the importance of working with the best partners in the supply chain. ITL is a great fit with OrganOx given their track record of successfully bringing medical devices to the market coupled with UK HQ with a presence in the US and in China."

University Hospitals Birmingham is one of the European liver transplant units to have conducted clinical research into metra, which was featured last year in the BBC TV series Surgeons: At the Edge of Life.

Darius Mirza, professor of transplant surgery at University Hospitals Birmingham, said: "In the 30 years I've been involved with transplantation, there have been three or four events which have been game changers and I'm absolutely certain we are looking at a game changer that will change the way we practise organ storage and transplantation."

 

 

For further information contact: -

 

Mark Webster / Andrew Boteler

Gooch & Housego PLC

01460 256440

Mark Court / Sophie Wills / Catriona Flint

Buchanan

020 7466 5000

Patrick Robb / David Anderson

Investec Bank plc

020 7597 5970

 

 

 

 

Notes to editors

 

1. Gooch & Housego is a photonics technology business headquartered in Ilminster, Somerset, UK with operations in the USA and Europe. A world leader in its field, the company researches, designs, engineers and manufactures advanced photonic systems, components and instrumentation for applications in the Aerospace & Defence, Industrial, Life Sciences and Scientific Research sectors. World leading design, development and manufacturing expertise is offered across a broad range of complementary technologies.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAQLLFFKXFEBBZ
Date   Source Headline
18th Oct 20222:50 pmRNSHolding(s) in Company
26th Aug 20221:00 pmRNSDirector/PDMR Shareholding
19th Aug 202212:24 pmRNSNotification of Major Holdings
19th Aug 202212:19 pmRNSNotification of Major Holdings
17th Aug 202212:00 pmRNSDirector/PDMR Shareholding
17th Aug 202211:57 amRNSDirector/PDMR Shareholding
17th Aug 202211:54 amRNSDirector/PDMR Shareholding
17th Aug 20227:00 amRNSTrading Update and Directorate Changes
13th Jun 202212:58 pmRNSHolding(s) in Company
7th Jun 20227:00 amRNSInterim Results
23rd May 20224:41 pmRNSSecond Price Monitoring Extn
23rd May 20224:36 pmRNSPrice Monitoring Extension
11th May 20227:00 amRNSNotification of Half Year Results
5th Apr 20227:00 amRNSHalf Year Trading Update
23rd Feb 20221:11 pmRNSResult of AGM
23rd Feb 20227:00 amRNSAGM Trading Update
9th Feb 20224:35 pmRNSPrice Monitoring Extension
13th Jan 20227:00 amRNSGrant of LTIP Awards
12th Jan 202212:18 pmRNSHolding(s) in Company
30th Dec 20214:41 pmRNSSecond Price Monitoring Extn
30th Dec 20214:36 pmRNSPrice Monitoring Extension
17th Dec 20217:00 amRNSPosting of Annual Report and AGM Notice
30th Nov 20217:00 amRNSResults for the year ended 30 September 2021
17th Nov 20217:00 amRNSNotification of Full Year Results
25th Oct 20214:41 pmRNSSecond Price Monitoring Extn
25th Oct 20214:35 pmRNSPrice Monitoring Extension
5th Oct 20217:00 amRNSFull Year Trading Update
18th Aug 20217:00 amRNSDiversity Underpins Competitive Advantage
27th Jul 202112:20 pmRNSUpdate on 2021 AGM Resolutions
9th Jun 20213:58 pmRNSPosting of Interim Report
3rd Jun 20217:00 amRNSHolding(s) in Company
1st Jun 20217:00 amRNSInterim Results
10th May 20217:00 amRNSNotification of Half Year Results
28th Apr 20213:20 pmRNSHolding(s) in Company
7th Apr 20217:00 amRNSHalf Year Trading Update
26th Mar 20217:00 amRNSGrant of SAYE Options
12th Mar 20217:00 amRNSAppointment of Non-Executive Director
11th Mar 20214:59 pmRNSPCA to the Chairman Share Purchase
24th Feb 20211:01 pmRNSResult of AGM
24th Feb 20217:00 amRNSAGM Trading Update
8th Feb 202110:20 amRNSHolding(s) in Company
22nd Jan 20214:40 pmRNSSecond Price Monitoring Extn
22nd Jan 20214:35 pmRNSPrice Monitoring Extension
7th Jan 202112:17 pmRNSGrant of LTIP Awards
23rd Dec 20207:00 amRNSLaunch of Satellite Laser Communication System
18th Dec 20207:00 amRNSPosting of Annual Report and AGM Notice
1st Dec 20207:00 amRNSPreliminary Results
16th Nov 20207:00 amRNSNotification of Full Year Results
6th Oct 20207:00 amRNSFull Year Trading Update
2nd Sep 20207:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.